It occurs because semaglutide slows digestion and gut movement
Novo Nordisk, the Danish drugmaker that manufactures three of the most popular formulations Ozempic, Rybelsus, and Wegovy is conducting a pregnancy registry for Wevogy (the only one of the three approved for use specifically in weight loss), in which it will compare pregnancy outcomes for people exposed to Wegovy during pregnancy, and overweight and obese people who were not exposed during pregnancy
About IV and Injection Therapy Unlike oral supplements, IV and injection therapies bypass the digestive system, delivering hydration, vitamins, and essential nutrients directly, to allow for better absorption and greater effectiveness
Their specific role depends on the formulation
This can lead to cell damage, inflammation, and a higher risk of diseases like heart problems and brain disorders
A Detailed Breakdown Certified Sports Dietitian Medical Disclaimer This article is for informational purposes only and does not constitute medical advice